ABBN.SW: $85.78 ▼ -0.32 (-0.37%)ASML.AS: $1,568.00 ▲ 7.20 (0.46%)ENR.DE: $161.14 ▼ -1.36 (-0.84%)GLEN.L: $537.10 ▲ 1.80 (0.34%)IFX.DE: $81.30 ▲ 0.74 (0.92%)NOKIA.HE: $12.18 ▲ 0.18 (1.46%)RIO.L: $7,296.00 ▲ 32.00 (0.44%)AMD: $519.85 ▼ -31.78 (-5.76%)INTC: $132.28 ▼ -8.66 (-6.14%)MU: $1,051.77 ▼ -159.61 (-13.18%)WDC: $670.75 ▼ -61.87 (-8.45%)AAPL: $294.30 ▼ -2.71 (-0.91%)AMZN: $234.11 ▲ 1.32 (0.57%)NVDA: $200.04 ▼ -8.61 (-4.13%)AMAT: $585.88 ▼ -54.30 (-8.48%)CIEN: $459.85 ▼ -0.48 (-0.10%)STX: $1,038.59 ▼ -55.45 (-5.07%)

Company Details

Cyclo Therapeutics, Inc.

CYTHW - NASDAQ

Identifiants & Marche

Ticker CYTHW
ISIN US23254X1101
CIK 0000922247
Bourse NASDAQ
Devise USD

Classification

Secteur Healthcare
Industrie Drug Manufacturers - Specialty & Generic

Entreprise

Pays US
Siege N/A
Fondee N/A
Site Web Lien

Description

Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.
Voir l'evolution du cours Retour